Aterian Investment Partners Acquires Contract Pharmaceuticals Limited

Altasciences Acquires Alliance Contract Pharma

February 27, 2020

Pharmaceuticals

Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.

Aterian Investment Partners Acquires ATCO Industries, Inc.

May 24, 2022

Industrial Services

Aterian Investment Partners, a New York-based private equity firm, has acquired ATCO Industries, Inc., a Sterling Heights, Michigan provider of tech-enabled testing, measurement and quality containment services for the North American automotive industry. Stellus Capital Management and LBC Credit Partners provided financing for the transaction; advisors included Kirkland & Ellis, William Blair, Deloitte Corporate Finance and Honigman LLP.

Aterian Investment Partners Partners with Kane Communications, LLC

August 2, 2021

Telecommunications

Aterian Investment Partners announced a strategic partnership with Kane Communications, LLC, a Trenton, New Jersey-based provider of structured cabling and telecommunications/utility infrastructure services. Aterian said it formed a holding company to support Kane as a platform for nationwide expansion through organic growth and M&A, and will partner with founder Melissa Kane on the growth plan.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Aterian Investment Partners Announces Partnership With PJ Mechanical

September 9, 2019

HVAC & Mechanical

Aterian Investment Partners, a New York-based private investment firm, has entered into a strategic partnership with PJ Mechanical, a leading full-service mechanical contractor based in New York City. The investment will support PJ Mechanical's next phase of growth while preserving the company's family-led culture and continuing to serve large commercial, healthcare and infrastructure clients across the NYC market.

Arlington Capital Partners Makes Majority Investment in Afton Scientific

January 30, 2024

Pharmaceuticals

Arlington Capital Partners has made a majority investment in Afton Scientific, a Charlottesville-based CDMO specializing in sterile injectable drug manufacturing and related lab/packaging services. The partnership will support Afton's capacity growth and expansion of service offerings while founder and CEO Tom Thorpe remains a material shareholder and will continue to lead the company.